Systematic Reviews
Copyright ©The Author(s) 2019.
World J Clin Cases. Feb 6, 2019; 7(3): 311-319
Published online Feb 6, 2019. doi: 10.12998/wjcc.v7.i3.311
Table 2 Celiac disease published cases – paraclinical characteristics
IndexNoDiagnosis
HemogramCoagulation
BiopsyEMAtTGDGP/AGA
[26]1Yes, Marsh 3c-P, 608 U-Hb – L (7.8 g/dL), PLT – LINR – H (2.1), aPTT – H (45 s)
[22]1YesPPP--
[10]1Yes-P (> 100 U)-Hb – H (15.8 g/dL)-
[27]1Yes, Marsh 3c-P (99 U/mL)-Hb – L (9.3 g/dL)INR – H (3.2)
[28]1Yes-P (132 U)-Hb – L (4.8-12.2 g/dL)INR – H (1.3)
[25]1Yes, Marsh 3c-P (48 U)P/(39 U)Hb – L (11.0 g/dL)-
[12]1Yes----INR – H (3.5)
[29]1Yes, Marsh 4-P (19 UI/mL)---
[30]2YesP (3+)P (200 RU/mL)-Hb – L (8.1 g/dL), PLT – L (180000/dL)-
YesP (+1)P (200 RU/mL)Hb – L (7.6 g/dL), PLT – L (156000/dL)-
[31]1Yes, Marsh 4PP (> 200 U/mL)PHb – L (8.7 g/dL)-
[32]1Yes---Hb – L-
[33]1YesP (> 1/1280)--Hb – NR (12.3 g/dL)-
[34]1YesPN---
[35]1Yes, Marsh 3NNNHb – NR (12.4 g/dL), PLT – L (160000/dL)-
[16]12Yes 12/12, ≥ Marsh 3a-P, 10/11---
[14]1Yes, Marsh 3P (92 U/mL)-P/(20 U/mL)--
[23]1YesP (1:160)P (15 EU/mL)---
[36]1Yes, Marsh 3b-P (33.9 U/L)P/(41.9 U/L)Hb – NR, PLT – L (94000/dL)-
[37]1Yes, Marsh 4-P (> 200 U/mL)-Hb – L (4.7 g/dL)-
[38]1Yes, Marsh 3cPP-Hb – L (7.2 g/dL), PLT – L (257000/dL)INR – H (> 1.5), aPTT – H (154 s)
[39]1Yes, Marsh 4NN---
[40]1Yes, Marsh 3cP (35.9 U)P (20.6 U)-Hb – NR (15.2 g/dL)INR – H (1.6)
[41]1Yes, Marsh 3P (158.7)P (> 200 U/mL)-Hb - L (9.4 g/dL)-
[15]1Yes, Marsh 3PPAGA PHb - L (8 g/dL)-
[13]1Yes, Marsh 3c-P (23.4, positive > 12)AGA P (27.4)HT - L (18%)PT < 10%
[42]1Yes, Marsh 3b--AGA P (IgA 63.4, IgG 111.1)Hb - L-
[8]2Yes, Marsh 3a; Yes, Marsh 3bP; P-AGA N; AGA PHb - L (5.9 /dL); Hb - L (7.9 /dL)PT prolonged (19 s); PT prolonged (18 s)
[43]1Yes, Marsh 3c---Hb - L-
[44]1Yes, Marsh 3cP (1:640)P (142)AGA PHb - L (11.6 g/dL)INR – H (1.6)